Skip to main content
NanoVibronix, Inc. logo

NanoVibronix, Inc. — Investor Relations & Filings

Ticker · NAOV ISIN · US63008J7028 LEI · 5493008114LTFZQ2I595 US Manufacturing
Open in API
Filings indexed 512 across all filing types
Latest filing 2020-09-24 Regulatory Filings
Country US United States of America
Listing US NAOV

About NanoVibronix, Inc.

https://nanovibronix.com/

NanoVibronix, Inc. is a medical technology company that develops non-invasive and minimally invasive biological response-activating devices. The company's core technology is based on a proprietary, patented low-intensity surface acoustic wave (SAW) ultrasound. Its main products include PainShield®, a portable device for pain therapy and the treatment of nerve and soft tissue damage, and UroShield®, an ultrasound device designed to prevent bacterial biofilm on urinary catheters. These prescription-based products offer therapeutic alternatives to medication for pain management, wound healing, and biofilm prevention, targeting both clinical and home care settings.

Recent filings

Filing Released Lang Actions
424B5 Filing
Regulatory Filings
2020-09-24 English
FWP Filing
Regulatory Filings
2020-09-23 English
FWP Filing
Regulatory Filings
2020-09-23 English
Capital/Financing Update 2020
Capital/Financing Update Classification · 100% confidence The document is a preliminary prospectus supplement filed pursuant to Rule 424(b)(5) under the Securities Act, related to an offering of common stock by NanoVibronix, Inc. It includes detailed information about the offering terms, underwriting, risk factors, use of proceeds, and other related disclosures. This type of document is a capital raising filing that updates or supplements a registration statement and prospectus for a securities offering. It is not an annual or quarterly report, earnings release, management discussion, or any other type of financial report. It is specifically a capital/financing update related to a securities offering. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content support a high confidence in this classification.
2020-09-22 English
Regulatory Filings 2020
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The text includes a press release about the FDA exercising enforcement discretion for a device, attached as an exhibit. There are no financial statements or detailed financial data presented. The document is short (3291 characters) and primarily serves as an announcement of an event rather than a detailed report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2020-09-22 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-09-04 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.